{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T03:39:16Z","timestamp":1747193956357,"version":"3.40.5"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2022,1,25]]},"DOI":"10.1161\/circulationaha.121.056728","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T19:00:25Z","timestamp":1643050825000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Letter by Costantine et al Regarding Article, \u201cPravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia\u201d"],"prefix":"10.1161","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-0006","authenticated-orcid":true,"given":"Maged M.","family":"Costantine","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus (M.M.C.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Lawrence-Cleary","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Yale University, New Haven, CT (K.L.-C.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Saade","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The University of Texas Medical Branch, Galveston (G.S.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Wapner","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Columbia University, New York, NY (R.J.W.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.053963"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1011293108"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.120147"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.05.018"},{"key":"e_1_3_2_6_2","unstructured":"US Food and Drug Administration. FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins. Published 2021. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.121.056728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T07:54:31Z","timestamp":1715586871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.121.056728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,1,25]]}},"alternative-id":["10.1161\/CIRCULATIONAHA.121.056728"],"URL":"https:\/\/doi.org\/10.1161\/circulationaha.121.056728","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"type":"print","value":"0009-7322"},{"type":"electronic","value":"1524-4539"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"assertion":[{"value":"2022-01-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}